A study to determine incidence of immunotherapy induced inflammatory response in glioblastoma patients pooled from academic centers
Latest Information Update: 10 Jun 2020
At a glance
- Drugs Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
Most Recent Events
- 10 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology